| Samarkos, Michael |
| Recruiting | 2/3 | 182 | Europe | Placebo, Anakinra 149 MG/ML Prefilled Syringe [Kineret] | Hellenic Institute for the Study of Sepsis | Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID | 08/25 | 08/25 | | |
| Completed | 2 | 44 | Europe | Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians | Hellenic Institute for the Study of Sepsis | Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality | 06/23 | 06/23 | | |
| Dimitroulis, Ioannis |
| Recruiting | 3 | 330 | Europe | Clarithromycin 500mg, A β-lactam/β-lactamase inhibitor or a 3rd generation cephalosporin or a fluoroquinolone, Tablets | Hellenic Institute for the Study of Sepsis | Community-acquired Pneumonia | 11/25 | 01/26 | | |
| Recruiting | 2/3 | 182 | Europe | Placebo, Anakinra 149 MG/ML Prefilled Syringe [Kineret] | Hellenic Institute for the Study of Sepsis | Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID | 08/25 | 08/25 | | |
| Completed | 2 | 60 | Europe | Anakinra Prefilled Syringe, Kineret, Placebo, NaCl | Hellenic Institute for the Study of Sepsis | Community-acquired Pneumonia, Hospital-acquired Pneumonia | 06/24 | 06/24 | | |
